Loading clinical trials...

Psychological Treatment in Psychiatric Inpatient Care | Clinical Trials | Clareo Health

TERMINATEDNA

Psychological Treatment in Psychiatric Inpatient Care

NCT06012981•Uppsala University

Summary

This study aims to investigate the effect of a brief psychotherapeutic treatment intervention based on ACT, aimed specifically at the vulnerable group of patients in psychiatric 24-hour care treated according to LPT. The study aims to investigate whether a brief number of therapeutic sessions according to ACT during inpatient care produce positive effects on personally relevant life areas for a diagnostically mixed group of patients in a psychiatric intensive care unit.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•18 years old or older.
•Treated according to the compulsory psychiatric care act.
•Meet the criterion of informed consent.

Exclusion Criteria

•Lack the cognitive ability to acquire the treatment intervention, such as impaired attention, memory, logic and reasoning, and also auditory and visual processing. This will be based on a clinical assessment by the ward team, including the attending psychiatrist and a clinical psychologist.
•Ongoing psychological treatment parallel to the admission.

Locations (1)

Hospital of Västmanland, Västerås

Västerås, Västmanland County, Sweden

Key Dates

Start Date

September 1, 2023

Primary Completion Date

November 15, 2023

Completion Date

November 15, 2023

Last Updated

December 20, 2023

Enrollment

ACTUAL participants

Conditions

Compulsory Psychiatric Care ActPsychosisAcceptance & Commitment TherapyPsychiatric HospitalizationPsychiatric Disorder

Interventions

ACT

BEHAVIORAL

A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis

NCT07226895

Clinical High Risk for Psychosis (CHR)

View study

RECRUITINGPHASE2/PHASE3

ACP-204 in Adults With Alzheimer's Disease Psychosis

NCT06159673

Alzheimer's Disease Psychosis

View study

RECRUITING

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

NCT06740383

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 20, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Psychological Treatment in Psychiatric Inpatient Care

Inclusion Criteria

Exclusion Criteria

A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis

ACP-204 in Adults With Alzheimer's Disease Psychosis

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders

Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis

Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to Reduce Pain and Improve Physical Function.